Ocrevus 300mg (IV) Ocrelizumab
Intended for healthcare professionals only
This material should not be used as a substitute for professional medical advice or to promote any medication. For more information, please consult your physician
Ocrevus is a CD20-directed cytolytic antibody indicated for the treatment of:
Relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
Primary progressive MS, in adults.
Full prescribing information is available on request.
If you have a scientific query related to one of Roche's products, please contact us at [email protected]
In case of any adverse events or safety queries, please contact [email protected]
M-PK-00002297
Solutions
Pharma Products
![[Product] Ocrevus](https://assets.roche.com/f/169232/768x511/c3767fe82e/ocrevus.jpg/m/320x180/filters:format(webp):quality(90)/)